Maplight Therapeutics Inc (MPLT)

$16.75 -1.59 (-8.67%)
Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) -77.58M
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 656,800
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts Strong Buy
Price Target N/A
Latest News on MPLT
MapLight Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares

Oct 29, 2025, 9:06 AM EDT - 1 day ago

MapLight Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares

MapLight Therapeutics valued at $787 million as shares jump in Nasdaq debut

Oct 27, 2025, 11:48 AM EDT - 3 days ago

MapLight Therapeutics valued at $787 million as shares jump in Nasdaq debut

MapLight Therapeutics Announces Pricing of Initial Public Offering

Oct 26, 2025, 5:30 PM EDT - 4 days ago

MapLight Therapeutics Announces Pricing of Initial Public Offering

US IPO Weekly Recap: 5 Small IPOs Debut, As Government Shutdown Drags On

Oct 25, 2025, 5:43 AM EDT - 5 days ago

US IPO Weekly Recap: 5 Small IPOs Debut, As Government Shutdown Drags On

AGCC AHMA ARM BGIN IPO IPOS KVUE

MapLight Therapeutics Starts $100 Million IPO Effort For CNS Treatments

Sep 24, 2025, 2:14 PM EDT - 5 weeks ago

MapLight Therapeutics Starts $100 Million IPO Effort For CNS Treatments

MapLight Therapeutics IPO Registration Document (S-1)

Sep 19, 2025, 4:11 PM EDT - 5 weeks ago

MapLight Therapeutics IPO Registration Document (S-1)

CNS disorder biotech MapLight Therapeutics files for a $100 million IPO

Sep 19, 2025, 6:15 AM EDT - 5 weeks ago

CNS disorder biotech MapLight Therapeutics files for a $100 million IPO